Covance

John Q. Kamerud, Ph.D. has been named associate director of immunochemistry services at Covance. Dr. Kamerud will lead Covance’s North American principal investigator teams providing large molecule bioanalytical services.

Dr. Kamerud joins Covance from Eli Lily & Co., where he served as research advisor and principal investigator for the bioanalytical and toxicokinetic phase of good laboratory practice (GLP) studies. In this role, he provided scientific collaboration for the bioanalytical phase of clinical studies to ensure quality and regulatory compliance.

Dr. Kamerud also represented ADME on cross-functional teams, providing scientific consultation and expertise, including study design, selecting drug candidates for development, and preparation of regulatory submissions. His background also includes product development experience in the Clinical Diagnostics industry.